Status:
RECRUITING
Patient-Reported Outcomes and Quality of Life in Adult and Pediatric Patients With Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL)
Lead Sponsor:
St. Jude Children's Research Hospital
Conditions:
Nodular Lymphocyte-Predominant Hodgkin Lymphoma
Eligibility:
All Genders
8+ years
Brief Summary
There is a pressing need to measure patient-reported symptoms in patients of all ages diagnosed with nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL). This study aims to measure longitudinal sy...
Detailed Description
The broad aim of this study is to develop the foundational data management infrastructure required to prospectively collect longitudinal electronic patient-reported outcomes (PROs) survey instruments ...
Eligibility Criteria
Inclusion
- Inclusion Criteria
- Age ≥ 8 years
- Patient or their adult proxy must have verbal and written English language proficiency.
- Pathologically confirmed diagnosis of nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL); patients with evidence of transformed lymphoma at diagnosis or subsequent development of transformed lymphoma after diagnosis are eligible.
- Patients or their adult proxy must be able to provide consent.
- Patients and/or adult proxy must be able to complete electronic quality of life surveys
- Exclusion Criteria
- Age 7 years or less.
- Patient or adult proxy does not have verbal and written English language proficiency.
- Patients with histologic evidence of a composite lymphoma (NLPHL with a concurrent diagnosis of Hodgkin lymphoma, indolent non-Hodgkin lymphoma, or gray zone lymphoma) at diagnosis are not eligible.
- Inability or unwillingness of research participant or legal guardian/representative to give consent.
Exclusion
Key Trial Info
Start Date :
April 4 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
January 31 2028
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT06098430
Start Date
April 4 2024
End Date
January 31 2028
Last Update
August 26 2025
Active Locations (5)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Colorado Hospital
Aurora, Colorado, United States, 80045
2
Dana-Farber Cancer Institute
Boston, Massachusetts, United States, 02215
3
Memorial Sloan Kettering Cancer Center
New York, New York, United States, 10065
4
The University of Rochester Medical Center
Rochester, New York, United States, 14642